Cointime

ActoGeniX

company

About

A biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs.

  • 251 - 500

Highlights

Total Funding Amount
€33.50M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€20M
Industries
Biopharma,Biotechnology,Clinical Trials,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
251 - 500
Operating Status
Active

ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs.

ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€33.50M
ActoGeniX has raised a total of €33.50M in funding over 2 rounds. Their latest funding was raised on Feb 11, 2009 from a Private Equity（PE） round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 11, 2009 Private Equity（PE） €13.50M 2 — — Detail
Feb 8, 2007 Series Unknown €20M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
ActoGeniX is funded by 2 investors. Biotech Fund Flanders and Baekeland Funds are the most recent investors.
Investor Name Lead Investor Funding Round
Biotech Fund Flanders — Private Equity（PE）
Baekeland Funds — Private Equity（PE）
Cointime
เนื้อหา
บริษัท